Makers Laboratories Ltd.
Snapshot View

124.00 -0.25 ▼-0.2%

25 November 2022, 04:01:00 PM
Volume: 3,519

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.makerslabs.com
Market Cap 73.11 Cr.
Enterprise Value(EV) 74.05 Cr. 2022-09
Financial Indicators
Earnings per share (EPS) -1.42 Trailing Twelve Months Ending 2022-09
Price-Earning Ratio (PE) - Trailing Twelve Months Ending 2022-09
Industry PE 35.02 Trailing Twelve Months Ending 2022-09
Book Value / Share 121.51 Trailing Twelve Months Ending 2022-09
Price to Book Value 1.02 Calculated using Price: 124.00
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 0.59 Cr. 5,900,376 Shares
FaceValue 10
Company Profile
Makers Laboratories was incorporated in 1985. The company is promoted and managed by Ipca Laboratories group. The company is engaged in manufacturing pharmaceutical formulations and drug intermediaries. The company's plants are located in Palghar and Dombivli in Thane (Maharashtra). The company has a prominent presence in the therapeutic segment of antibiotics.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-0.20%
1 Week
-1.94%
1 Month
-10.79%
3 Month
-18.69%
6 Month
-23.93%
1 Year
-40.29%
2 Year
-7.42%
5 Year
+36.19%
10 Year
+564.52%
2 years 2021-03 2022-03
Return on Equity (%) 2.49 20.61
Return on Capital Employed (%) 6.53 24.00
Return on Assets (%) 0.99 8.35

Balance Sheet View Details >>

Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09* Rs. Cr.
Shh. Funds 54 60 72
Non Curr. Liab. 17 13 11
Curr. Liab. 33 33 33
Minority Int. 32 39 39
Equity & Liab. 136 144 156
Non Curr. Assets 75 81 87
Curr. Assets 61 63 68
Misc. Exp. not W/O
Total Assets 136 144 156

Profit Loss View Details >>

Particulars 3 years 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-09 Rs. Cr. TTM
Net Sales 69 127 109
Other Income 1 3 4
Total Income 70 130 113
Total Expenditure -61 -108 -100
PBIDT 9 21 12
Interest -2 -2 -2
Depreciation -5 -4 -4
Taxation -1 -4 -2
Exceptional Items 0 0
PAT 1 12 4
Minority Interest -2 -7 -5
Share Associate
Other Related Items
Consolidated Net Profit 0 5 -1
Adjusted EPS -1 10 -1

Cash Flow View Details >>

Particulars 2 years 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. 9
Cash Fr. Inv. -12
Cash Fr. Finan. 0
Net Change -3
Cash & Cash Eqvt 2

Shareholding Pattern View Details >>

9 Qtrs 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%)
Promoter 58.37 58.37 58.37 58.37 58.37 58.37 58.37 61.27 61.27
Public 41.63 41.63 41.63 41.63 41.63 41.63 41.63 38.73 38.73
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Announcements View Details >>

Fri, 25 Nov 2022
Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Compliance under Regulation 39(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015
Tue, 15 Nov 2022
Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper publication for Unaudited Q2FY23 Results
Mon, 14 Nov 2022
Board Meeting Outcome for Standalone And Consolidated Unaudited Financial Results For The 2Nd Quarter And Half Year Ended 30Th September 2022
We are enclosing herewith our Standalone and Consolidated Unaudited Financial Results along with limited review reports of the Companys Auditors thereon for the 2nd Quarter and half year ended 30th September 2022 which was taken on record at the Meeting of the Board of Directors of the Company held today at Kandivli Mumbai.

Technical Scans View Details >>

Fri, 25 Nov 2022
High Delivery Percentage High Delivery Percentage
Higher Delivery Quantity Higher Delivery Quantity
Higher Delivery Quantity and Percentage Higher Delivery Quantity and Percentage
Higher Trade Quantity Higher Trade Quantity
Higher Trade and Delivery Quantity Higher Trade and Delivery Quantity

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 247,923.28 1,033.85 -0.1%
Cipla Ltd. 89,193.72 1,105.35 +0.9%
Divi's Laboratories Ltd. 88,708.98 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. 73,559.75 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. 68,713.97 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. 55,107.38 1,628.25 +0.8%
Abbott India Ltd. 43,050.55 20,267.50 +0.4%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 60.40 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 34.75 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 29.59 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 23.60 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 82.06 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 69.14 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 48.82 20,267.50 +0.4%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-09 4.67 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-09 4.07 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-09 7.30 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-09 3.53 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-09 11.51 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-09 9.05 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-09 15.86 20,267.50 +0.4%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 0.04 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 0.00 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 13.10 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 29.95 20,267.50 +0.4%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 4,919.27 20,267.50 +0.4%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 1,033.85 -0.1%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,105.35 +0.9%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,342.65 +1.1%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,418.10 +0.1%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,789.45 -0.5%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,628.25 +0.8%
Abbott India Ltd. Standalone 2022-03 798.70 20,267.50 +0.4%

FAQ's On Makers Laboratories Ltd.

What is Makers Laboratories share price?

Can I buy Makers Laboratories shares now?

What is the Market Cap of Makers Laboratories?

What are the key metrics to analyse Makers Laboratories?

What is the 52 Week High and Low of Makers Laboratories?

What is the trend of Makers Laboratories share price?